Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Features
72 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Feature Story
Wearable Technology: Innovation, Adherence, and Clinical Outcomes
PAP-Q4-20-NI-002
Feature Story
Wearable Technology: Targeting a Range of Uses and Indications
PAP-Q4-20-NI-003
Feature Story
Wearable Technology: Their Future in Clinical Trials and the Real World
PAP-Q4-20-NI-004
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
PAP-Q3-20-NI-002
Feature Story
The Growing Importance of Local Manufacturing and Nearby Outsourcing Partners
PAP-Q3-20-NI-003
Feature Story
Rethinking the Global Pharmaceutical Supply Chain Post-COVID-19
PAP-Q3-20-NI-004
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
PAP-Q2-20-NI-001
Molecules
Molecules that Changed Medicine
PAP-Q2-20-NI-002
Coping with COVID-19
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
PAP-Q2-20-NI-004
Capacity Expansion
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility
PR-M04-20-NI-032
COVID-19
COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic
PAO-Q2-20-NI-001
M&A
M&A: Fundamental to Pharma Industry Growth
PAP-Q1-20-NI-002
Nice Insight Overview
Understanding a Dynamic Industry Through Mergers and Acquisitions
PAP-Q1-20-NI-001
Microbiome
Reflections on a 10-Year Journey in the Microbiome
PAP-Q1-20-CL-006
Gene Therapy
Introduction: The Promise & Challenge of Gene Therapy
PAP-Q4-19-NI-008
Gene Therapy
Gene Therapy R&D Accelerates
PAP-Q4-19-NI-002
Gene Therapy
Overcoming the Manufacturing Roadblock
PAP-Q4-19-NI-003
Gene Therapy
Promise Amid Challenges: Logistics of the Cell and Gene Therapy Supply Chain
PAP-Q4-19-NI-004
Glocalization
Introduction: Glocalization
PAP-Q3-19-NI-003
Worldwide Clinical Trials
The Relevance of Global Clinical Trials
PAP-Q3-19-NI-002
Glocalization
Glocalization of Drug Manufacturing
PAP-Q3-19-NI-003
Glocalization
From Regulatory Convergence to Global Regulatory Harmonization
PAP-Q3-19-NI-004
Orphan Drug Development
An Expanding Orphan Drug Market
PAP-Q2-2019-NI-001
Orphan Drug Development
Managing the Risks Associated with Orphan Drug Development and Manufacturing
PAP-Q2-2019-NI-002
1
3
»
